Based on the DHTRF stock forecast from 0 analysts, the average analyst target price for DHTRF is not available over the next 12 months. DHTRF’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of DHTRF is Slightly Bullish , which is based on 6 positive signals and 5 negative signals. At the last closing, DHTRF’s stock price was USD 7.92. DHTRF’s stock price has changed by -3.49% over the past week, -3.55% over the past month and -36.13% over the last year.
No recent analyst target price found for DHTRF
No recent average analyst rating found for DHTRF
Company Overview DHTRF
DRI Healthcare Trust focuses on managing and growing a portfolio of pharmaceutical royalties. It owns a portfolio of 18 royalties derived from the sale of 14 various pharmaceutical products that focuses on eight therapeutic areas. The company was incorporated in 2020 and is headquartered in Toronto, Canada. Read Less
DRI Healthcare Trust focuses on managing and growing a portfolio of pharmaceutical royalties. It owns a portfolio of 18 royalties derived from the sale of 14 various pharmaceutical products that focuses on eight therapeutic areas. The company was incorporated in 2020 and is headq...Read More
Frequently Asked Questions About DHTRF (DHTRF) Stock
Stock Target Advisor's fundamental analysis for DHTRF's stock is Slightly Bullish .
DHTRF stock's dividend yield is 4.93%.
Our analysis grades DHTRF stock's dividend yield at A. This means that DHTRF stock's dividend yield is above 96% of the stocks in the Drug Manufacturers - Specialty & Generic sector in the OTC exchange.
Based on this DHTRF may be a good dividend stock for its sector.
Unfortunately we do not have enough data on DHTRF's stock to indicate what its average analyst target is.
DHTRF stock's Price/Earning ratio is 48.56.
Our analysis grades DHTRF stock's Price / Earning ratio at F. This means that DHTRF stock's Price/Earning ratio is above 83% of the stocks in the Drug Manufacturers - Specialty & Generic sector in the OTC exchange.
Based on this DHTRF may be a overvalued for its sector.
The last closing price of DHTRF's stock was USD 7.92.
The most recent market capitalization for DHTRF is USD 0.46B.
Unfortunately we do not have enough analyst data on DHTRF's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains DHTRF's stock.
As per our most recent records DHTRF has 0 Employees.
DHTRF's registered address is 100 King Street West, Toronto, ON, Canada, M5X 1B1.
You can get more information about it from DHTRF's website at https://www.dricapital.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Below median total returns
The company has under performed its peers on annual average total returns in the past 5 years.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Frequently Asked Questions About DHTRF (DHTRF) Stock
Stock Target Advisor's fundamental analysis for DHTRF's stock is Slightly Bullish .
DHTRF stock's dividend yield is 4.93%.
Our analysis grades DHTRF stock's dividend yield at A. This means that DHTRF stock's dividend yield is above 96% of the stocks in the Drug Manufacturers - Specialty & Generic sector in the OTC exchange.
Based on this DHTRF may be a good dividend stock for its sector.
Unfortunately we do not have enough data on DHTRF's stock to indicate what its average analyst target is.
DHTRF stock's Price/Earning ratio is 48.56.
Our analysis grades DHTRF stock's Price / Earning ratio at F. This means that DHTRF stock's Price/Earning ratio is above 83% of the stocks in the Drug Manufacturers - Specialty & Generic sector in the OTC exchange.
Based on this DHTRF may be a overvalued for its sector.
The last closing price of DHTRF's stock was USD 7.92.
The most recent market capitalization for DHTRF is USD 0.46B.
Unfortunately we do not have enough analyst data on DHTRF's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains DHTRF's stock.
As per our most recent records DHTRF has 0 Employees.
DHTRF's registered address is 100 King Street West, Toronto, ON, Canada, M5X 1B1.
You can get more information about it from DHTRF's website at https://www.dricapital.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for DHTRF !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
